<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03613376</url>
  </required_header>
  <id_info>
    <org_study_id>97/2018</org_study_id>
    <nct_id>NCT03613376</nct_id>
  </id_info>
  <brief_title>Compression And Functional Ability After Endovenous Varicose Vein Treatment</brief_title>
  <official_title>Compression And Functional Ability After Endovenous Varicose Vein Treatment</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Oulu University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Oulu University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Study's aim is to study possible differences in post-operative rehabilitation, functional
      ability and visual disturbances after endovascular varicose intervention (RF-catheter and
      foam sclerotherapy) in two study groups, where patients will be randomised to either no
      compression group (Group I) or compression group (Group II)
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 21, 2018</start_date>
  <completion_date type="Anticipated">December 21, 2020</completion_date>
  <primary_completion_date type="Anticipated">May 21, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Post-operative pain</measure>
    <time_frame>10days recorded daily</time_frame>
    <description>Visual Analog Scale (VAS) 0-100mm</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Functional ability, other than pain</measure>
    <time_frame>10 days recorded daily</time_frame>
    <description>Visual Analog Scale 0-100mm indicating post-operative functional ability reduction</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Aberdeen Varicose Veins Questionnaire (AVVQ)</measure>
    <time_frame>Assessed preoperatively and at 2 months</time_frame>
    <description>Score from 0 to 99.658</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Visual appearance of varicose veins, patient assessment</measure>
    <time_frame>Preoperatively and at 2 months</time_frame>
    <description>Patient self-assessment (Patient Self-Assessment of Visible Varicose Veins, PA-V score)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Signs of deep venous thrombosis hematoma</measure>
    <time_frame>Assessed at 2 months and earlier if necessary</time_frame>
    <description>Ultrasound assessment</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time required returning to normal activity</measure>
    <time_frame>14 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time required returning to full activity</measure>
    <time_frame>14 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative pigmentation</measure>
    <time_frame>at 2 months</time_frame>
    <description>Pigmentation is monitored from standardised photographs on severity of pigmentation and most severe tone of post-operative pigmentation compared to base skin colour, reviewers are blinded to study group.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Visual appearance of varicose veins, expert assessment</measure>
    <time_frame>Preoperatively and at 2 months</time_frame>
    <description>Photography Review -Visible Varicose Veins (IPR-V score, reviewers are blinded to time point and study group).</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">106</enrollment>
  <condition>Varicose Veins of Lower Limb</condition>
  <condition>Varicose Veins</condition>
  <arm_group>
    <arm_group_label>No Compression</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Patients in this group will not receive any compression after treatment</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Compression</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients in this group will use class II compression stockings continuously until next evening and then next 4 days during daytime.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Class II compression stockings</intervention_name>
    <description>Patients in this group will use class II compression stocking continuously until next evening and then next 4 days during daytime</description>
    <arm_group_label>Compression</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Duplex ultrasound verified GSV, AASV and/or SSV incompetence suitable for
             radiofrequency ablation

          -  Comprehensive Classification System for Chronic Venous Disorders (CEAP) rated from C2
             to C4

          -  Distal varicose vein insufficiency suitable for sclerotherapy

          -  Patient willingness to participate

        Exclusion Criteria:

          -  History of pulmonary embolism or deep venous thrombosis

          -  Large (&gt;12mm) truncal vein diameter

          -  CEAP C5-C6

          -  Antithrombotic medication (ASA accepted)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Matti Pokela, Docent</last_name>
    <phone>+31583152011</phone>
    <email>matti.pokela@ppshp.fi</email>
  </overall_contact>
  <location>
    <facility>
      <name>Oulu University Hospital, Vascular Department</name>
      <address>
        <city>Oulu</city>
        <zip>90220</zip>
        <country>Finland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Matti Pokela, Docent</last_name>
      <phone>+35883152011</phone>
      <email>matti.pokela@ppshp.fi</email>
    </contact>
    <investigator>
      <last_name>Toni Pihlaja, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Finland</country>
  </location_countries>
  <verification_date>August 2019</verification_date>
  <study_first_submitted>May 27, 2018</study_first_submitted>
  <study_first_submitted_qc>July 29, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">August 3, 2018</study_first_posted>
  <last_update_submitted>August 27, 2019</last_update_submitted>
  <last_update_submitted_qc>August 27, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">August 28, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Oulu University Hospital</investigator_affiliation>
    <investigator_full_name>Toni Pihlaja</investigator_full_name>
    <investigator_title>Vascular specialist</investigator_title>
  </responsible_party>
  <keyword>Varicose veins</keyword>
  <keyword>Compression stockings</keyword>
  <keyword>Sclerotherapy</keyword>
  <keyword>Radiofrequency ablation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Varicose Veins</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

